1. Home
  2. NEO vs HSAI Comparison

NEO vs HSAI Comparison

Compare NEO & HSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

N/A

Current Price

$15.00

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Logo Hesai Group each ADS represents one Class B ordinary share

HSAI

Hesai Group each ADS represents one Class B ordinary share

N/A

Current Price

$13.12

Market Cap

2.4B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NEO
HSAI
Founded
2001
2014
Country
United States
China
Employees
N/A
N/A
Industry
Precision Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
NEO
HSAI
Price
$15.00
$13.12
Analyst Decision
Buy
Strong Buy
Analyst Count
11
19
Target Price
★ $23.40
$23.30
AVG Volume (30 Days)
1.6M
★ 2.0M
Earning Date
10-28-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$11.12
$23.90
Revenue Next Year
$9.68
$35.15
P/E Ratio
★ N/A
$61.18
Revenue Growth
N/A
N/A
52 Week Low
$7.07
$12.00
52 Week High
$20.15
$29.35

Technical Indicators

Market Signals
Indicator
NEO
HSAI
Relative Strength Index (RSI) 35.28 44.46
Support Level $13.43 $12.01
Resistance Level $15.31 $14.77
Average True Range (ATR) 0.80 0.59
MACD -0.20 0.06
Stochastic Oscillator 3.34 32.39

Price Performance

Historical Comparison
NEO
HSAI

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.

Share on Social Networks: